Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs

Leishmaniasis is a serious medical issue in many countries around the World, but it remains largely neglected in terms of research investment for developing new control and treatment measures. No vaccines exist for human use, and the chemotherapeutic agents currently used are scanty. Furthermore, fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Rastrojo, Alberto, García-Hernández, Raquel, Vargas, Paola, Camacho, Esther, Corvo, Laura, Imamura, Hideo, Dujardin, Jean-Claude, Castanys, Santiago, Aguado, Begoña, Gamarro, Francisco, Requena, Jose M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039315/
https://www.ncbi.nlm.nih.gov/pubmed/29689531
http://dx.doi.org/10.1016/j.ijpddr.2018.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039315/
https://www.ncbi.nlm.nih.gov/pubmed/29689531
http://dx.doi.org/10.1016/j.ijpddr.2018.04.002

Ejemplares similares